0001843113-22-000010.txt : 20221018
0001843113-22-000010.hdr.sgml : 20221018
20221018203811
ACCESSION NUMBER: 0001843113-22-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221016
FILED AS OF DATE: 20221018
DATE AS OF CHANGE: 20221018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABALLI JOHN
CENTRAL INDEX KEY: 0001843113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39049
FILM NUMBER: 221317072
MAIL ADDRESS:
STREET 1: C/O DECIPHER BIOSCIENCES, INC.
STREET 2: 6925 LUSK BLVD, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXAGEN INC.
CENTRAL INDEX KEY: 0001274737
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
BUSINESS PHONE: (760) 560-1501
MAIL ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
FORMER COMPANY:
FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC
DATE OF NAME CHANGE: 20031230
4
1
wf-form4_166613985172902.xml
FORM 4
X0306
4
2022-10-16
0
0001274737
EXAGEN INC.
XGN
0001843113
ABALLI JOHN
C/O EXAGEN INC.
1261 LIBERTY WAY
VISTA
CA
92081
1
1
0
0
President and CEO
Restricted Stock Units
2022-10-16
4
A
0
350000
0
A
350000
D
The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of October 16, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control.
/s/ Kamal Adawi, as attorney-in-fact
2022-10-18